Hassoun PM. Pulmonary arterial hypertension. N Engl J Med Dec. 2021;16(25):2361–76. https://doi.org/10.1056/NEJMra2000348.
Coons JC, Pogue K, Kolodziej AR, Hirsch GA, George MP. Pulmonary arterial hypertension: a pharmacotherapeutic update. Curr Cardiol Rep Nov. 2019;22(11):141. https://doi.org/10.1007/s11886-019-1235-4.
Beshay S, Sahay S, Humbert M. Evaluation and management of pulmonary arterial hypertension. Respir Med. Sep 2020;171:106099. https://doi.org/10.1016/j.rmed.2020.106099.
Levine DJ. Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients. Am J Manag Care Mar. 2021;27(3 Suppl):S35–41. https://doi.org/10.37765/ajmc.2021.88609.
Swiston JR, Johnson SR, Granton JT. Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med Nov. 2010;104(11):1588–607. https://doi.org/10.1016/j.rmed.2010.08.003.
Vazquez ZGS, Klinger JR. Guidelines for the treatment of pulmonary arterial hypertension. Lung Aug. 2020;198(4):581–96. https://doi.org/10.1007/s00408-020-00375-w.
Agrawal V, Lahm T, Hansmann G, Hemnes AR. Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism. Cardiovasc Diagn Ther Oct. 2020;10(5):1522–40. https://doi.org/10.21037/cdt-20-404.
Talati M, Hemnes A. Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy. Pulm Circ Jun. 2015;5(2):269–78. https://doi.org/10.1086/681227.
Sanchez-Mut JV, Heyn H, Silva BA, Dixsaut L, Garcia-Esparcia P, Vidal E, Sayols S, Glauser L, Monteagudo-Sánchez A, Perez-Tur J. PM20D1 is a quantitative trait locus associated with Alzheimer’s disease. Nat Med. 2018;24(5):598–603.
Article CAS PubMed Google Scholar
Li M, Gao S, Kang M, Zhang X, Lan P, Wu X, Yan X, Dang H, Zheng J. Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway. Phytomedicine Aug. 2023;117:154908. https://doi.org/10.1016/j.phymed.2023.154908.
Huang X, He P, Wu L. Clinical significance of peptidase M20 domain containing 1 ii patients with carotid atherosclerosis. Arquivos brasileiros de cardiologia. 2022;119:372–9.
CAS PubMed PubMed Central Google Scholar
Hou J, Chen X, Xia J, Zhang L. Down-regulation of PM20D1 is associated with clinical outcomes and prognosis of pregnant patients with diabetes mellitus. Archives Med Sci. 2022.
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J Oct. 2022;11(38):3618–731. https://doi.org/10.1093/eurheartj/ehac237.
Strange G, Lau EM, Giannoulatou E, Corrigan C, Kotlyar E, Kermeen F, Williams T, Celermajer DS, Dwyer N, Whitford H, Wrobel JP, Feenstra J, Lavender M, Whyte K, Collins N, Steele P, Proudman S, Thakkar V, Keating D, Keogh A. Survival of idiopathic pulmonary arterial hypertension patients in the modern era in Australia and New Zealand. Heart Lung Circ Nov. 2018;27(11):1368–75. https://doi.org/10.1016/j.hlc.2017.08.018.
Badagliacca R, Poscia R, Pezzuto B, Papa S, Reali M, Pesce F, Manzi G, Gianfrilli D, Ciciarello F, Sciomer S, Biondi-Zoccai G, Torre R, Fedele F, Vizza CD. Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension. J Heart Lung Transpl Oct. 2017;2. https://doi.org/10.1016/j.healun.2017.09.026.
Zhang Y, Chen Y, Yao H, Lie Z, Chen G, Tan H, Zhou Y. Elevated serum circ_0068481 levels as a potential diagnostic and prognostic indicator in idiopathic pulmonary arterial hypertension. Pulm Circ Oct-Dec. 2019;9(4):2045894019888416. https://doi.org/10.1177/2045894019888416.
Hu EC, He JG, Liu ZH, Ni XH, Zheng YG, Gu Q, Zhao ZH, Xiong CM. High levels of serum lactate dehydrogenase correlate with the severity and mortality of idiopathic pulmonary arterial hypertension. Exp Ther Med Jun. 2015;9(6):2109–13. https://doi.org/10.3892/etm.2015.2376.
Xu XQ, Lv ZC, Liu QQ, Zhao QH, Wu Y, Sun K, Jiang X, Wang L, Peng FH, Jing ZC. Direct bilirubin: a new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. Int J Cardiol Feb 1. 2017;228:895–9. https://doi.org/10.1016/j.ijcard.2016.11.036.
Zhang R, Wang L, Zhao QH, Jiang R, Gong SG, Jiang X, Xu XQ, He YY, Li Y, Jing ZC. Alteration of Extracellular Superoxide dismutase in idiopathic pulmonary arterial hypertension. Front Med (Lausanne). 2020;7:509. https://doi.org/10.3389/fmed.2020.00509.
Jonas K, Waligóra M, Magoń W, Zdrojewski T, Stokwiszewski J, Płazak W, Podolec P, Kopeć G. Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension. Arch Med Sci Oct. 2019;15(6):1397–406. https://doi.org/10.5114/aoms.2018.79242.
Matsubara H, Ogawa A. Treatment of idiopathic/hereditary pulmonary arterial hypertension. J Cardiol Oct. 2014;64(4):243–9. https://doi.org/10.1016/j.jjcc.2014.06.009.
Li D, Liu Y, Gao W, Han J, Yuan R, Zhang M, Pang W. Inhibition of mir-324-5p increases PM20D1-mediated white and brown adipose loss and reduces body weight in juvenile mice. Eur J Pharmacol Nov. 2019;15:863:172708. https://doi.org/10.1016/j.ejphar.2019.172708.
Liu Y, Wang J, Zhou X, Cao H, Zhang X, Huang K, Li X, Yang G, Shi X. Mir-324-5p inhibits C2C12 cell differentiation and promotes intramuscular lipid deposition through lncDUM and PM20D1. Mol Ther Nucleic Acids Dec. 2020;4:22:722–32. https://doi.org/10.1016/j.omtn.2020.09.037.
Dana R, Bannay A, Bourst P, Ziegler C, Losser MR, Gibot S, Levy B, Audibert G, Ziegler O. Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes (Lond) Sep. 2021;45(9):2028–37. https://doi.org/10.1038/s41366-021-00872-9.
Karampela I, Chrysanthopoulou E, Christodoulatos GS, Dalamaga M. Is there an obesity Paradox in critical illness? Epidemiologic and metabolic considerations. Curr Obes Rep Sep. 2020;9(3):231–44. https://doi.org/10.1007/s13679-020-00394-x.
Noronha NY, Barato M, Sae-Lee C, Pinhel MAS, Watanabe LM, Pereira VAB, Rodrigues GDS, Morais DA, de Sousa WT Jr., Souza VCO, Plaça JR, Salgado W Jr., Barbosa F Jr., Plösch T, Nonino CB. Novel zinc-related differentially methylated regions in leukocytes of women with and without obesity. Front Nutr. 2022;9:785281. https://doi.org/10.3389/fnut.2022.785281.
Article CAS PubMed PubMed Central Google Scholar
Snipelisky D, Jentzer J, Batal O, Dardari Z, Mathier M. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension. Clin Cardiol Jun. 2018;41(6):782–7. https://doi.org/10.1002/clc.22954.
Comments (0)